A detailed history of Kbc Group Nv transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Kbc Group Nv holds 228,304 shares of JAZZ stock, worth $26.8 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
228,304
Previous 377,853 39.58%
Holding current value
$26.8 Million
Previous $40.3 Million 36.93%
% of portfolio
0.08%
Previous 0.12%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$100.57 - $116.37 $15 Million - $17.4 Million
-149,549 Reduced 39.58%
228,304 $25.4 Million
Q2 2024

Jul 17, 2024

BUY
$103.94 - $118.98 $8.29 Million - $9.49 Million
79,797 Added 26.77%
377,853 $40.3 Million
Q1 2024

May 08, 2024

BUY
$115.19 - $132.77 $15.5 Million - $17.8 Million
134,198 Added 81.9%
298,056 $35.9 Million
Q4 2023

Feb 13, 2024

BUY
$114.26 - $136.0 $17.9 Million - $21.3 Million
156,707 Added 2191.4%
163,858 $20.2 Million
Q3 2023

Feb 15, 2024

BUY
$122.0 - $145.31 $405,162 - $482,574
3,321 Added 46.44%
10,472 $1.36 Million
Q2 2023

Feb 15, 2024

SELL
$122.5 - $147.16 $12.7 Million - $15.2 Million
-103,391 Reduced 93.53%
7,151 $887,000
Q2 2023

Jul 28, 2023

SELL
$122.5 - $147.16 $3.04 Million - $3.66 Million
-24,849 Reduced 77.65%
7,151 $887,000
Q1 2023

Feb 14, 2024

SELL
$133.98 - $160.47 $7.37 Million - $8.83 Million
-54,995 Reduced 63.22%
32,000 $4.68 Million
Q1 2023

May 04, 2023

SELL
$133.98 - $160.47 $10.5 Million - $12.6 Million
-78,446 Reduced 71.03%
32,000 $4.68 Million
Q4 2022

Feb 14, 2024

SELL
$129.72 - $159.85 $4.65 Million - $5.73 Million
-35,847 Reduced 29.18%
86,995 $13.9 Million
Q3 2022

Feb 15, 2024

SELL
$126.59 - $161.18 $6.75 Million - $8.59 Million
-53,316 Reduced 32.54%
110,542 $14.7 Million
Q3 2022

Nov 08, 2022

SELL
$126.59 - $161.18 $1.55 Million - $1.98 Million
-12,261 Reduced 9.99%
110,446 $14.7 Million
Q2 2022

Feb 14, 2024

BUY
$141.59 - $168.66 $7.77 Million - $9.25 Million
54,861 Added 80.7%
122,842 $19.2 Million
Q2 2022

Jul 26, 2022

BUY
$141.59 - $168.66 $7.75 Million - $9.23 Million
54,726 Added 80.5%
122,707 $19.1 Million
Q1 2022

Feb 14, 2024

BUY
$129.64 - $160.7 $7.05 Million - $8.74 Million
54,408 Added 400.85%
67,981 $10.6 Million
Q1 2022

May 06, 2022

BUY
$129.64 - $160.7 $7.05 Million - $8.74 Million
54,408 Added 400.85%
67,981 $10.6 Million
Q4 2021

Feb 14, 2024

SELL
$119.87 - $145.67 $18 Million - $21.9 Million
-150,285 Reduced 91.72%
13,573 $1.73 Million
Q4 2021

Feb 03, 2022

SELL
$119.87 - $145.67 $14,144 - $17,189
-118 Reduced 0.86%
13,573 $1.73 Million
Q3 2021

Nov 10, 2021

SELL
$128.64 - $184.79 $16.4 Million - $23.6 Million
-127,481 Reduced 90.3%
13,691 $1.78 Million
Q2 2021

Aug 11, 2021

BUY
$160.2 - $186.42 $16.7 Million - $19.5 Million
104,555 Added 285.54%
141,172 $25.1 Million
Q1 2021

Apr 26, 2021

BUY
$150.19 - $173.5 $524,763 - $606,209
3,494 Added 10.55%
36,617 $6.02 Million
Q4 2020

Feb 10, 2021

BUY
$140.71 - $165.05 $3.22 Million - $3.78 Million
22,872 Added 223.12%
33,123 $5.47 Million
Q3 2020

Oct 28, 2020

SELL
$105.46 - $144.13 $250,889 - $342,885
-2,379 Reduced 18.84%
10,251 $1.46 Million
Q2 2020

Aug 10, 2020

SELL
$95.68 - $121.88 $3.9 Million - $4.97 Million
-40,763 Reduced 76.35%
12,630 $1.39 Million
Q1 2020

May 04, 2020

SELL
$87.74 - $152.74 $7.98 Million - $13.9 Million
-90,940 Reduced 63.01%
53,393 $5.33 Million
Q4 2019

Feb 11, 2020

BUY
$117.65 - $153.73 $4.14 Million - $5.42 Million
35,227 Added 32.29%
144,333 $21.5 Million
Q3 2019

Nov 07, 2019

BUY
$125.18 - $143.24 $13.6 Million - $15.5 Million
108,276 Added 13045.3%
109,106 $14 Million
Q2 2019

Dec 03, 2019

SELL
$125.55 - $144.48 $12.9 Million - $14.8 Million
-102,503 Reduced 99.2%
830 $118,000
Q2 2019

Jul 30, 2019

BUY
$125.55 - $144.48 $12.9 Million - $14.8 Million
102,503 Added 12349.76%
103,333 $0
Q1 2019

Dec 03, 2019

SELL
$121.81 - $142.95 $12.4 Million - $14.5 Million
-101,541 Reduced 99.19%
830 $119,000
Q1 2019

May 10, 2019

BUY
$121.81 - $142.95 $12.4 Million - $14.5 Million
101,541 Added 12233.86%
102,371 $0
Q4 2018

Dec 03, 2019

SELL
$115.94 - $166.74 $18.6 Million - $26.8 Million
-160,783 Reduced 99.49%
830 $103,000
Q4 2018

Jan 31, 2019

BUY
$115.94 - $166.74 $18.6 Million - $26.8 Million
160,783 Added 19371.45%
161,613 $20 Million
Q3 2018

Dec 03, 2019

SELL
$161.01 - $180.57 $21.5 Million - $24.1 Million
-133,676 Reduced 99.38%
830 $140,000
Q3 2018

Nov 14, 2018

BUY
$161.01 - $180.57 $21.5 Million - $24.1 Million
133,676 Added 16105.54%
134,506 $0
Q2 2018

Dec 03, 2019

SELL
$146.33 - $183.18 $15.8 Million - $19.8 Million
-108,205 Reduced 99.24%
830 $143,000
Q2 2018

Aug 03, 2018

BUY
$146.33 - $183.18 $15.8 Million - $19.8 Million
108,205 Added 13036.75%
109,035 $0
Q1 2018

Dec 03, 2019

SELL
$135.59 - $157.16 $17.4 Million - $20.1 Million
-127,967 Reduced 99.36%
830 $125,000
Q1 2018

May 09, 2018

BUY
$135.59 - $157.16 $17.4 Million - $20.1 Million
127,967 Added 15417.71%
128,797 $0
Q4 2017

Dec 03, 2019

SELL
$131.06 - $150.39 $23.5 Million - $27 Million
-179,556 Reduced 99.54%
830 $112,000
Q4 2017

Feb 07, 2018

BUY
$131.06 - $150.39 $23.5 Million - $27 Million
179,556 Added 21633.25%
180,386 $0
Q3 2017

Dec 03, 2019

SELL
$142.62 - $155.6 $35.9 Million - $39.2 Million
-251,873 Reduced 99.67%
830 $121,000
Q3 2017

Nov 13, 2017

BUY
$142.62 - $155.6 $35.9 Million - $39.2 Million
251,873 Added 30346.14%
252,703 $0
Q2 2017

Dec 03, 2019

BUY
N/A
830
830 $129,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.37B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.